Skip to main content
SpringerLink
Log in

Patients’ attitudes on how to deal with the risk of future stone recurrences

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

One hundred consecutive patients referred for active stone removal responded to a number of questions regarding their attitude to metabolic risk evaluation and recurrence prevention. Of the 74 men and 26 women all but one were interested in the cause of their disease. While 95% of the patients were motivated to change their dietary habits, only 71% were interested in pharmacological treatment. Collection of 24-h urine for risk evaluation in one or five fractions was acceptable to 94 and 84% of the patients, respectively. Only 79% wanted to collect urine during more than one 24-h period. Given the option of a recurrence prevention programme or active stone removal when or if a stone appeared, approximately half of our patients (52%) chose the first, and about one-third (29%) of them chose the second alternative, whereas as many as 19% of the patients did not express any opinion. A programme for regular follow-up in order to detect new stones early was appreciated by only 81 patients. These results show that biochemical risk evaluation and recurrence prevention is generally met with a positive attitude by most patients and that medical recurrence prevention appears to be appreciated by more than half of the patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ahlstrand C, Tiselius HG (1990) Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 18:397–399

    Article  PubMed  CAS  Google Scholar 

  2. Tiselius HG (2000) Stone incidence and prevention. Braz J Urol 26:453–462

    Google Scholar 

  3. Trinchieri A, Ostini F, Nespoli R, Revera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after first renal stone. J Urol 162:27–30

    Article  PubMed  CAS  Google Scholar 

  4. Strohmaier WL (2004) Course of renal stone disease—an epidemiological view. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis. The Hong Kong Polytechnic University, Hong Kong (MDI Gohel), pp 377–385

    Google Scholar 

  5. Robertson WG, Peacock M, Nordin BEC (1968) Activity products in stone-forming and non-stone forming urine. Clin Sci 34:579–594

    Google Scholar 

  6. Finlayson B (1974) Renal lithiasis in review. Urol Clin North Am 1:181–211

    PubMed  CAS  Google Scholar 

  7. Nancollas GH (1976) The kinetics of crystal growth and renal stoneformation. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis research. Plenum, New York, pp 5–23

    Google Scholar 

  8. Smith LH (1989) Medical aspects of urolithiasis: overview. J Urol 141:707–710

    PubMed  CAS  Google Scholar 

  9. Baumann M (1990) Physico-chemical aspects of calcium stone formation. Urol Res 18:25–30

    Article  Google Scholar 

  10. Hess B, Tiselius HG (2002) Physical–chemical processes in kidney stone formation. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism (2 edn) Williams & Wilkins, Lippincott, pp 619–628

    Google Scholar 

  11. Tiselius HG (2000) Comprehensive metabolic evaluation of stone formers is cost effective. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger G (eds) Urolithiasis 2000. Proceedings of the 9th international symposium on urolithiasis. University of Cape Town, Cape Town, pp 349–355

    Google Scholar 

  12. Tiselius HG (2004) Routine metabolic evaluation of patients with stone disease—aspects on its cost effectiveness. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis, The Hong Kong Polytechnic University, Hong Kong, (MDI Gohel), pp 372–376

    Google Scholar 

  13. Tiselius HG, Advisory Board of European Urolithiasis Research EAU Health Care Office Working Party for Urolithiasis (2001) Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 88:1–16

    Google Scholar 

  14. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Callucci M (2001) Guidelines on urolithiasis. (Abbreviated version). Eur Urol 40:362–371

    Article  PubMed  CAS  Google Scholar 

  15. Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36–41

    Article  PubMed  CAS  Google Scholar 

  16. Hess B, Mauron H, Ackermann D, Jaeger Ph (1999) Effects of a “common sense diet” on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 1999 36:136–143

    Article  CAS  Google Scholar 

  17. Pattras JG, Moore RG (1999) Citrate in the management of urolithiasis. J Endourol 13:687–691

    Google Scholar 

  18. Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium–magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073

    Article  PubMed  CAS  Google Scholar 

  19. Lee YH, Huang WC, Tsai JY, Hung JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453–1457

    Article  PubMed  CAS  Google Scholar 

  20. Hofbauer J, Höbarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate nephrolithiasis—a prospective randomized study. Br J Urol 73:362–365

    PubMed  CAS  Google Scholar 

  21. Hess B, Hasler-Strub U, Ackermann D, Jaeger Ph (1997) Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 12:1362–1368

    Article  PubMed  CAS  Google Scholar 

  22. Höbarth K, Hofbauer J, Szabo N (1994) Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology 44:20–25

    Article  PubMed  Google Scholar 

  23. Tiselius HG (1994) Investigation of single and recurrent stone formers. Miner Electrolyte Metab 20:321–327

    PubMed  CAS  Google Scholar 

  24. Bek-Jensen H, Tiselius HG (1998) Repeated urine analysis in patients with calcium stone disease. Eur Urol 33:323–332

    Article  PubMed  CAS  Google Scholar 

  25. Tiselius HG (1997) Metabolic evaluation of patients with stone disease. Urol Int 59:131–141

    Article  PubMed  CAS  Google Scholar 

  26. Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167:1607–1612

    Article  PubMed  Google Scholar 

  27. Grampsas SA, Moore M, Chandhoke PS (2000) 10-year experience with extracorporeal shockwave lithotripsy in the state of Colorado. J Endourol 14:711–714

    Article  PubMed  CAS  Google Scholar 

  28. Laerum E (1984) Recurrent urolithiasis: a general-practice study of risk factors and clinical consequences. Scand J Urol Nephrol 18:67–70

    PubMed  CAS  Google Scholar 

  29. Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthiazide reduces calcium oxalate calculus recurrences but magnesium hydroxide does not. J Urol 139:679–684

    PubMed  CAS  Google Scholar 

  30. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H (1992) Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69:571–576

    Article  PubMed  CAS  Google Scholar 

  31. Borghi L, Meschi T, Guerra A, Novanni A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(suppl 6):78–86

    Google Scholar 

  32. Ahlstrand C, Sandwall K, Tiselius HG (1996) Prophylactic treatment of calcium stone formers with hydrochlorothiazide and magnesium. In: Tiselius HG (eds) Renal stones—aspects on their formation, removal and prevention. Proceedings of the Sixth European Symposium on Urolithiasis 1995. Akademitryck AB, Edsbruk, pp 195–197

    Google Scholar 

  33. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761–1764

    PubMed  CAS  Google Scholar 

  34. Tuncel A, Biri H, Küpeli B, Tan Ö, Sen I (2003) Efficiency of long-term potassium citrate treatment in patients with calcium oxalate stone disease. In: Sarica K, Kyagci F, Erbagci A, Inal Y (eds) Proceedings of the 2nd Eurolithiasis Society Meeting. Abstract. ReTa offset publishing, Gaziantep, p 273

    Google Scholar 

  35. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M, Knoll T (2006) Guidelines on Urolithiasis. European Association of Urology (EAU Guidelines office)

Download references

Acknowledgments

The assistance by Monica Bollvik, Marita Fredriksson, Elsie-Marie Jonason and Kristina Sjöström in completing this study is highly appreciated.

Author information

Authors and Affiliations

  1. The Renal Stone Unit, Department of Urology, Karolinska University Hospital and the Division of Urology, Huddinge and Karolinska Institutet, 141 86, Stockholm, Sweden

    Hans-Göran Tiselius

Authors
  1. Hans-Göran Tiselius
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Göran Tiselius.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tiselius, HG. Patients’ attitudes on how to deal with the risk of future stone recurrences. Urol Res 34, 255–260 (2006). https://doi.org/10.1007/s00240-006-0056-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-006-0056-2

Keywords

Search

Navigation